Article

Almost 7 million adult Americans have had a stroke.
There is a growing need for
more effective treatment options as add-ons to conventional therapies. This
article summarizes the published literature for pharmacologic agents used for the
enhancement of motor and speech recovery after stroke. Amphetamine, levodopa,
selective serotonin reuptake inhibitors, and piracetam were the most commonly
used drugs. Pharmacologic augmentation of stroke motor and speech recovery seems
promising but systematic, adequately powered, randomized, and double-blind
clinical trials are needed.
At this point, the use of these pharmacologic agents
is not supported by class I evidence.
CI - Copyright (c) 2015 Elsevier Inc. All rights reserved.

Langue : ANGLAIS